Cumberland Pharmaceuticals Inc. Revenue Breakdown
No Revenue Breakdown for CPIX on this site yet.
- 2025-12-31: Others Not split by product in the filing$44.52M100.00%; Total revenue $44.52M.
- 2024-12-31: Others Not split by product in the filing$37.87M100.00%; Total revenue $37.87M.
- 2023-12-31: Others Not split by product in the filing$39.55M100.00%; Total revenue $39.55M.
- 2022-12-31: Others Not split by product in the filing$42.01M100.00%; Total revenue $42.01M.
Source checked: the stored Revenue Breakdown page for CPIX.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $44.52M 100.00% | $44.52M |
| 2024-12-31 | Not split by product in the filing $37.87M 100.00% | $37.87M |
| 2023-12-31 | Not split by product in the filing $39.55M 100.00% | $39.55M |
| 2022-12-31 | Not split by product in the filing $42.01M 100.00% | $42.01M |
| 2021-12-31 | Not split by product in the filing $35.05M 100.00% | $35.05M |
| 2020-12-31 | Not split by product in the filing $35.84M 100.00% | $35.84M |
| 2019-12-31 | Not split by product in the filing $32.41M 100.00% | $32.41M |
| 2018-12-31 | Not split by product in the filing $28.80M 100.00% | $28.80M |
| 2017-12-31 | Not split by product in the filing $25.55M 100.00% | $25.55M |
| 2016-12-31 | Not split by product in the filing $32.48M 100.00% | $32.48M |
| 2015-12-31 | Not split by product in the filing $900.00K 100.00% | $900.00K |
| 2014-12-31 | Not split by product in the filing $600.00K 100.00% | $600.00K |
| 2013-12-31 | Not split by product in the filing $800.00K 100.00% | $800.00K |
| 2012-12-31 | Not split by product in the filing $700.00K 100.00% | $700.00K |
| 2011-12-31 | Not split by product in the filing $51.14M 100.00% | $51.14M |
| 2010-12-31 | Not split by product in the filing $45.88M 100.00% | $45.88M |
| 2009-12-31 | Not split by product in the filing $43.54M 100.00% | $43.54M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $8.80M 100.00% | $8.80M |
| 2026-03-31 | Not split by product $9.13M 100.00% | $9.13M |
| 2025-12-31 | Not split by product $13.68M 100.00% | $13.68M |
| 2025-09-30 | Not split by product $8.29M 100.00% | $8.29M |
| 2025-06-30 | Not split by product $10.84M 100.00% | $10.84M |
| 2025-03-31 | Not split by product $11.71M 100.00% | $11.71M |
| 2024-12-31 | Not split by product $10.44M 100.00% | $10.44M |
| 2024-09-30 | Not split by product $9.09M 100.00% | $9.09M |
| 2024-06-30 | Not split by product $9.85M 100.00% | $9.85M |
| 2024-03-31 | Not split by product $8.50M 100.00% | $8.50M |
| 2023-12-31 | Not split by product $9.35M 100.00% | $9.35M |
| 2023-09-30 | Not split by product $10.09M 100.00% | $10.09M |
| 2023-06-30 | Not split by product $10.89M 100.00% | $10.89M |
| 2023-03-31 | Not split by product $9.22M 100.00% | $9.22M |
| 2022-12-31 | Not split by product $9.12M 100.00% | $9.12M |
| 2022-09-30 | Not split by product $11.41M 100.00% | $11.41M |
| 2022-06-30 | Not split by product $10.30M 100.00% | $10.30M |
| 2022-03-31 | Not split by product $11.18M 100.00% | $11.18M |
| 2021-12-31 | Not split by product $7.38M 100.00% | $7.38M |
| 2021-09-30 | Not split by product $8.07M 100.00% | $8.07M |
| 2021-06-30 | Not split by product $9.06M 100.00% | $9.06M |
| 2021-03-31 | Not split by product $10.54M 100.00% | $10.54M |
| 2020-12-31 | Not split by product $8.66M 100.00% | $8.66M |
| 2020-09-30 | Not split by product $9.25M 100.00% | $9.25M |
| 2020-06-30 | Not split by product $9.60M 100.00% | $9.60M |
| 2020-03-31 | Not split by product $8.33M 100.00% | $8.33M |
| 2019-12-31 | Not split by product $7.33M 100.00% | $7.33M |
| 2019-09-30 | Not split by product $6.94M 100.00% | $6.94M |
| 2019-06-30 | Not split by product $9.42M 100.00% | $9.42M |
| 2019-03-31 | Not split by product $8.73M 100.00% | $8.73M |
| 2018-12-31 | Not split by product $1.56M 100.00% | $1.56M |
| 2018-09-30 | Not split by product $8.49M 100.00% | $8.49M |
| 2018-06-30 | Not split by product $10.16M 100.00% | $10.16M |
| 2018-03-31 | Not split by product $8.59M 100.00% | $8.59M |
| 2017-12-31 | Not split by product -$3.95M 100.00% | -$3.95M |
| 2017-09-30 | Not split by product $11.20M 100.00% | $11.20M |
| 2017-06-30 | Not split by product $8.67M 100.00% | $8.67M |
| 2017-03-31 | Not split by product $9.64M 100.00% | $9.64M |
| 2016-12-31 | Not split by product $9.08M 100.00% | $9.08M |
| 2016-09-30 | Not split by product $8.79M 100.00% | $8.79M |
| 2016-06-30 | Not split by product $7.41M 100.00% | $7.41M |
| 2016-03-31 | Not split by product $7.74M 100.00% | $7.74M |
| 2015-12-31 | Not split by product $8.04M 100.00% | $8.04M |
| 2015-09-30 | Not split by product $7.89M 100.00% | $7.89M |
| 2015-06-30 | Not split by product $8.91M 100.00% | $8.91M |
| 2015-03-31 | Not split by product $8.69M 100.00% | $8.69M |
| 2014-12-31 | Not split by product $9.33M 100.00% | $9.33M |
| 2014-09-30 | Not split by product $9.73M 100.00% | $9.73M |
| 2014-06-30 | Not split by product $9.75M 100.00% | $9.75M |
| 2014-03-31 | Not split by product $8.09M 100.00% | $8.09M |
| 2013-12-31 | Not split by product $8.16M 100.00% | $8.16M |
| 2013-09-30 | Not split by product $6.53M 100.00% | $6.53M |
| 2013-06-30 | Not split by product $7.08M 100.00% | $7.08M |
| 2013-03-31 | Not split by product $10.26M 100.00% | $10.26M |
| 2012-12-31 | Not split by product $13.70M 100.00% | $13.70M |
| 2012-09-30 | Not split by product $12.53M 100.00% | $12.53M |
| 2012-06-30 | Not split by product $12.37M 100.00% | $12.37M |
| 2012-03-31 | Not split by product $10.26M 100.00% | $10.26M |
| 2011-12-31 | Not split by product $13.03M 100.00% | $13.03M |
| 2011-09-30 | Not split by product $13.05M 100.00% | $13.05M |
| 2011-06-30 | Not split by product $14.39M 100.00% | $14.39M |
| 2011-03-31 | Not split by product $10.67M 100.00% | $10.67M |
| 2010-12-31 | Not split by product $12.81M 100.00% | $12.81M |
| 2010-09-30 | Not split by product $12.19M 100.00% | $12.19M |
| 2010-06-30 | Not split by product $10.74M 100.00% | $10.74M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |